{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-089584","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2025-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.996698+00:00","generated_at":"2026-05-17T06:07:50.366440+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Jasper Therapeutics prices $30M public offering, updates BEACON CSU investigation progress","bullets":["Gross proceeds ~$30M from offering of 11.67M shares + warrants at $2.43/share; closing expected Sept 22.","BEACON CSU investigation rules out drug substance/product issues; focus shifts to clinical site activity.","Investigation completion expected in Q4 2025 with KOL panel review for Phase 2b CSU study integration.","Use of proceeds: continued development of briquilimab in mast-cell diseases and general corporate expenses.","Common warrants exercisable at $2.92, 6-month lockout, 4-year term; pre-funded warrants at $0.0001 exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-089584","json":"https://secwatch.observer/filing/0001213900-25-089584.json","markdown":"https://secwatch.observer/filing/0001213900-25-089584.md","text":"https://secwatch.observer/filing/0001213900-25-089584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390025089584/0001213900-25-089584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390025089584/ea0258026-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:07:50.366440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}